Skip to content
OpenCapital
Get started

Organon OGN Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net

Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net at other companies

Pfizer logo
PfizerPFE
——
Amgen logo
AmgenAMGN
——
PBH
Prestige Consumer HealthcarePBH
——
Kenvue logo
KenvueKVUE
——
Bausch + Lomb logo
Bausch + LombBLCO
——

Other financials

Income statement

See full
Revenue$1.5B-3.5%
Gross profit$783.0M-6.9%
Net income$146.0M+67.8%
EPS (diluted)$0.55+66.7%

Balance sheet

See full
Cash & equivalents$1.1B+104%
Total debt$8.6B-4.3%
Total equity$903.0M+66.6%
Total assets$13.0B-1.2%

Cash flow

See full
Operating cash flow$225.0M+200%
CapEx$37.0M+15.6%
Free cash flow$188.0M+337%

Valuation

See full
Market cap$3.53B-59.4%

Profitability

See full
Gross margin52.8%-4.4pp
Net margin8%-12.3pp
FCF margin11.1%-1.3pp

Returns & leverage

See full
Return on equity71.6%—
Debt / equity9.5×-7.0×
Current ratio2×+0.3×

Where this comes from

Reported directly by Organon in its filing.

Tagged under the XBRL concept us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet.

The official record: Organon’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organon's debt instrument, unamortized discount (premium) and debt issuance costs, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organon's debt instrument, unamortized discount (premium) and debt issuance costs, net?
Organon (OGN) reported debt instrument, unamortized discount (premium) and debt issuance costs, net of $77M in Q1 2026.
How has Organon's debt instrument, unamortized discount (premium) and debt issuance costs, net changed year-over-year?
Organon's debt instrument, unamortized discount (premium) and debt issuance costs, net decreased by 17.2% year-over-year, from $93M to $77M.
What is the long-term trend for Organon's debt instrument, unamortized discount (premium) and debt issuance costs, net?
Over 4 years (2021 to 2025), Organon's debt instrument, unamortized discount (premium) and debt issuance costs, net has grown at a -10.1% compound annual growth rate (CAGR), from $124M to $81M.